Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Michael Thakor (NPI 1629045364)

Field	Value
Entity Type	Individual
Organization	Michael Thakor
Address	2121 E Harmony Rd
City	Fort Collins
State	CO
ZIP	80528
Taxonomy	Rheumatology Physician
NPI Enumerated	March 1, 2006

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

This provider’s visible commercial footprint is effectively single-payer: lifetime Medicare revenue is $1.8M and there is no Medicaid billing on file ("none below"), so Medicare accounts for the entirety of recorded public-payer activity. The top three Medicare codes account for 68.8% of that Medicare revenue, indicating heavy concentration in a few high-revenue services.

The CPT/HCPCS mix is consistent with a rheumatology practice that delivers clinic-administered biologic infusions: top drug codes include J0129 (abatacept), J1745 (infliximab), J3262 (tocilizumab) and J9312 (rituximab), and the practice also bills infusion/chemotherapy administration codes such as 96413 and 96415. This pattern suggests the operation is set up to provide supervised, in-office infusion services rather than primarily prescribing self-administered injectables.

Revenue concentration is pronounced: J0129 accounts for $543.2K (29.2% of Medicare revenue), J1745 accounts for $490.9K (26.4%), and J3262 accounts for $245.6K (13.2%), which together are the precomputed top-3 mix making up 68.8% of total Medicare revenue. Reliance on these biologic/drug codes means changes in access, reimbursement, or formulary placement for these agents would materially affect the provider’s Medicare revenue.

J1745 (infliximab) is a national outlier: it generates $490.9K and the provider ranks #18 of 1352 providers nationally (99th percentile; "extreme outlier"), signaling this provider is a major national-volume site for infliximab infusions relative to peers. That standing suggests the practice either captures cross-market infusion demand or operates a high-throughput infusion service for this drug.

Other high-volume/high-percentile signals are mixed: 99213 (established office visits) appears as an "extreme outlier" with 1.6K claims and $105.2K (5.7% of Medicare revenue), indicating unusually high E&M visit volume relative to national peers, while J0129, J3262, and J9312 show more typical participation (83th, 62th, and 60th percentiles respectively). Together these data suggest the practice pairs frequent office/management visits with high-volume infusion therapy, rather than relying on office visits alone.

Infusion-administration codes further support an intensive infusion operation: 96413 (initial IV infusion) generates 580 claims and $62.6K (3.4% of Medicare revenue) and ranks in the 94th percentile ("notably above typical national volume"), while 96415 (additional hour add-on) has 522 claims, $12K (0.6%) and ranks #62 of 4959 providers (99th percentile; "extreme outlier"). High utilization of 96415 in particular implies many multi-hour infusion sessions and capacity for prolonged infusions.

The provider has regulatory longevity consistent with an established practice: NPI enumerated 2006-03-01 (~20 years ago), which suggests long-tenured operations in the Fort Collins market but a relatively modest cumulative Medicare revenue base of $1.8M given that tenure. This combination—long presence but concentrated revenue in a few infusion drugs—indicates a stable specialty clinic that may be tightly focused on biologic infusion services rather than broad ambulatory care.

From a payer and network strategy perspective, absence of Medicaid billing ("none below") means there is little to no Medicaid exposure to assess, concentrating financial risk and negotiating leverage entirely within Medicare and commercial channels. For payers and competing infusion providers, the provider’s national leadership on J1745 and heavy use of infusion add-ons positions it as an important node for infliximab access and infusion capacity, and changes in contracting or utilization management for these codes could materially shift referral flows and local infusion capacity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

20 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	15,980	$30	$543.1K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	18,880	$30	$490.9K
J3262	Injection, tocilizumab, 1 mg	49,120	$10	$245.6K
J9312	Injection, rituximab, 10 mg	3,850	$60	$242.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,640	$60	$105.2K
J0897	Injection, denosumab, 1 mg	4,500	$20	$81K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	580	$110	$62.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	360	$90	$32.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	190	$120	$21.3K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	240	$50	$12.8K

Showing 1–10 of 20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Michael Thakor — 5 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

20 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	3	30	6,280	$30	$250.4K
J9312	2	10	3,000	$60	$193.6K
J3262	5	20	28,180	$1	$158.6K
J1745	1	40	3,180	$30	$110.6K
J0897	38	140	2,580	$20	$68.8K
96413	3	140	130	$100	$19.7K
99214	735	8,160	80	$80	$11.3K
96365	35	170	100	$50	$9.5K
99213	3	7,200	70	$60	$6.6K
99205	1,007	1,300	20	$150	$5K

Showing 1–10 of 20

Related Providers

Other providers that share a Tax Identification Number (TIN) with Michael Thakor, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Denver Health And Hospital Authority	CO	General Practice Physician	$0	$95M
Denver Health And Hospital Authority	CO	General Acute Care Hospital	$0	$77.1M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$68.5M
Denver Health And Hospital Authority	CO	Ambulance	$3.4M	$46.3M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$40.3M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$29.4M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$28.2M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$25.5M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$17.4M
Denver Health And Hospital Authority	CO	Federally Qualified Health Center (FQHC)	$0	$15.2M

Nearby Providers

Other providers in the same ZIP code as Michael Thakor, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Harmony Surgery Center, LLC	CO	Ambulatory Surgical Clinic/Center	$5.4M	$2.8M
Noco Pediatric Ot, LLC	CO	Occupational Therapist	$0	$5.7M
Tender Care Pediatric Services, Inc	CO	In Home Supportive Care Agency	$0	$5.4M
Surgery Center Of Northern Colorado	CO	Ambulatory Surgical Clinic/Center	$4.3M	$702.8K
E Plus Pet Imaging Xviii LP	CO	Radiology Clinic/Center	$2.1M	$964.4K
Charles Sisson	CO	Pain Medicine (Anesthesiology) Physician	$2.6M	$0
Matthew Asano	CO	Ophthalmology Physician	$2M	$0
Harmony Imaging Center LLC	CO	Diagnostic Radiology Physician	$1.1M	$417.9K
Tamara Miller	CO	Specialist	$1.4M	$0
Joshua Petit	CO	Radiation Oncology Physician	$443.5K	$0

Michael Thakor — Billing Profile & Reimbursement Data

Sign up for Michael Thakor — Billing Profile & Reimbursement Data policy alerts

Michael Thakor — Billing Profile & Reimbursement Data

Sign up for Michael Thakor — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References